HL7 Belgium Vaccination (Patient Dossier)
1.1.0 - STU
This page is part of the HL7 Belgium FHIR Implementation Guide - Vaccination profiles (v1.1.0: Release) based on FHIR (HL7® FHIR® Standard) R4. This is the current published version. For a full list of available versions, see the Directory of published versions
Draft as of 2024-09-04 |
<CodeSystem xmlns="http://hl7.org/fhir">
<id value="be-cs-vaccination-administration-route"/>
<text>
<status value="generated"/>
<div xmlns="http://www.w3.org/1999/xhtml"><p class="res-header-id"><b>Generated Narrative: CodeSystem be-cs-vaccination-administration-route</b></p><a name="be-cs-vaccination-administration-route"> </a><a name="hcbe-cs-vaccination-administration-route"> </a><a name="be-cs-vaccination-administration-route-en-US"> </a><p>This case-sensitive code system <code>https://www.ehealth.fgov.be/standards/fhir/vaccination/CodeSystem/be-cs-vaccination-administration-route</code> defines the following codes:</p><table class="codes"><tr><td style="white-space:nowrap"><b>Code</b></td><td><b>Display</b></td></tr><tr><td style="white-space:nowrap">IM<a name="be-cs-vaccination-administration-route-IM"> </a></td><td>Instramuscular</td></tr><tr><td style="white-space:nowrap">SC<a name="be-cs-vaccination-administration-route-SC"> </a></td><td>Subcutaneous</td></tr><tr><td style="white-space:nowrap">IV<a name="be-cs-vaccination-administration-route-IV"> </a></td><td>Intravenous</td></tr><tr><td style="white-space:nowrap">ID<a name="be-cs-vaccination-administration-route-ID"> </a></td><td>Intradermal</td></tr><tr><td style="white-space:nowrap">Oral<a name="be-cs-vaccination-administration-route-Oral"> </a></td><td>Oral</td></tr><tr><td style="white-space:nowrap">Nasal<a name="be-cs-vaccination-administration-route-Nasal"> </a></td><td>Nasal</td></tr><tr><td style="white-space:nowrap">unknown<a name="be-cs-vaccination-administration-route-unknown"> </a></td><td>Unknown</td></tr></table><p><b>Additional Language Displays</b></p><table class="codes"><tr><td><b>Code</b></td><td><b>French (Belgium) (fr)</b></td><td><b>Nederlands (België) (Dutch (Belgium), nl)</b></td></tr><tr><td>IM</td><td>Intramusculaire</td><td>Intramusculaire</td></tr><tr><td>SC</td><td>Sous-cutanée</td><td>Subcutane</td></tr><tr><td>IV</td><td>intraveineuse</td><td>intraveneus</td></tr><tr><td>ID</td><td>Intradermique</td><td>Intradermale</td></tr><tr><td>Oral</td><td>Orale</td><td>Mondeling</td></tr><tr><td>Nasal</td><td>Nasal</td><td>Nasaal</td></tr><tr><td>unknown</td><td>Inconnu</td><td>onbekend</td></tr></table></div>
</text>
<url
value="https://www.ehealth.fgov.be/standards/fhir/vaccination/CodeSystem/be-cs-vaccination-administration-route"/>
<version value="1.1.0"/>
<name value="BeCSVaccineAdministrationRoute"/>
<title value="BeCSVaccineAdministrationRoute"/>
<status value="draft"/>
<experimental value="false"/>
<date value="2024-09-04T17:12:08+02:00"/>
<publisher value="eHealth Platform"/>
<contact>
<name value="eHealth Platform"/>
<telecom>
<system value="url"/>
<value value="http://www.ehealth.fgov.be/"/>
</telecom>
<telecom>
<system value="email"/>
<value value="support@be-ehealth-standards.atlassian.net"/>
</telecom>
</contact>
<contact>
<name value="Message Structure"/>
<telecom>
<system value="email"/>
<value value="support@be-ehealth-standards.atlassian.net"/>
<use value="work"/>
</telecom>
</contact>
<description value="Vaccine Administration Route"/>
<jurisdiction>
<coding>
<system value="urn:iso:std:iso:3166"/>
<code value="BE"/>
<display value="Belgium"/>
</coding>
</jurisdiction>
<caseSensitive value="true"/>
<content value="complete"/>
<count value="7"/>
<concept>
<code value="IM"/>
<display value="Instramuscular"/>
<designation>
<language value="fr-BE"/>
<value value="Intramusculaire"/>
</designation>
<designation>
<language value="nl-BE"/>
<value value="Intramusculaire"/>
</designation>
</concept>
<concept>
<code value="SC"/>
<display value="Subcutaneous"/>
<designation>
<language value="fr-BE"/>
<value value="Sous-cutanée"/>
</designation>
<designation>
<language value="nl-BE"/>
<value value="Subcutane"/>
</designation>
</concept>
<concept>
<code value="IV"/>
<display value="Intravenous"/>
<designation>
<language value="fr-BE"/>
<value value="intraveineuse"/>
</designation>
<designation>
<language value="nl-BE"/>
<value value="intraveneus"/>
</designation>
</concept>
<concept>
<code value="ID"/>
<display value="Intradermal"/>
<designation>
<language value="fr-BE"/>
<value value="Intradermique"/>
</designation>
<designation>
<language value="nl-BE"/>
<value value="Intradermale"/>
</designation>
</concept>
<concept>
<code value="Oral"/>
<display value="Oral"/>
<designation>
<language value="fr-BE"/>
<value value="Orale"/>
</designation>
<designation>
<language value="nl-BE"/>
<value value="Mondeling"/>
</designation>
</concept>
<concept>
<code value="Nasal"/>
<display value="Nasal"/>
<designation>
<language value="fr-BE"/>
<value value="Nasal"/>
</designation>
<designation>
<language value="nl-BE"/>
<value value="Nasaal"/>
</designation>
</concept>
<concept>
<code value="unknown"/>
<display value="Unknown"/>
<designation>
<language value="fr-BE"/>
<value value="Inconnu"/>
</designation>
<designation>
<language value="nl-BE"/>
<value value="onbekend"/>
</designation>
</concept>
</CodeSystem>